---
title: "688098.SH (688098.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688098.SH/news.md"
symbol: "688098.SH"
name: "688098.SH"
parent: "https://longbridge.com/en/quote/688098.SH.md"
datetime: "2026-05-20T22:42:38.116Z"
locales:
  - [en](https://longbridge.com/en/quote/688098.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688098.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688098.SH/news.md)
---

# 688098.SH (688098.SH) — Related News

### [](https://longbridge.com/en/news/285315987.md)
*2026-05-06T05:35:18.000Z*
> The A-share aquaculture industry experienced a volatile rise in the afternoon, with YISHENG rising over 4.5%. GUOLIAN AQ

### [Shen Lian Biomedical: Net profit loss of 1.731 million yuan in the first quarter of 2026](https://longbridge.com/en/news/284402386.md)
*2026-04-28T14:26:17.000Z*
> Shen Lian Biomedical announced that its operating revenue in the first quarter of 2026 was 62.5984 million yuan, a year-

### [](https://longbridge.com/en/news/281818527.md)
*2026-04-07T02:14:00.000Z*
> The animal health concept has rebounded sharply, with Shen Lian Biomedical hitting the limit up, and CAHIC, Hengtong, DA

### [Shen Lian Biomedical plans to acquire a controlling stake in Shizhiyuan for 237 million yuan, entering the field of innovative human drugs](https://longbridge.com/en/news/276833490.md)
*2026-02-25T04:52:16.000Z*
> Shen Lian Biomedical plans to acquire a controlling stake in Shizhi Yuan for 237 million yuan, entering the field of inn

### [688098 plans to acquire! The target company has 3 new drugs under development](https://longbridge.com/en/news/276763247.md)
*2026-02-24T16:01:40.000Z*
> Shen Lian Biomedical plans to acquire controlling interest in Shizhi Yuan for 237 million yuan. On February 24, Shen Lia

### [STAR Market Evening News | Shenghe Jingwei IPO Approved, Ucap Terminates Acquisition of Nanning Taike](https://longbridge.com/en/news/276737319.md)
*2026-02-24T13:02:16.000Z*
> Today's STAR Market Evening Report includes: Centec Communications IPO approved, Ucap terminates acquisition of Nanning 

### [Shen Lian Biomedical: Plans to use 237 million yuan to acquire controlling stake in joint venture company](https://longbridge.com/en/news/276712404.md)
*2026-02-24T09:39:20.000Z*
> Shen Lian Biomedical announced that it plans to use 237 million yuan to acquire a controlling stake in Yangzhou Shizhiyu

### [Shen Lian Biomedical: Shareholders holding more than 5% reduced their holdings by 3%, and the reduction plan has been completed](https://longbridge.com/en/news/275323408.md)
*2026-02-09T13:20:27.000Z*
> Shen Lian Biomedical announced that United BioPharma, Inc. holds 43.1999 million shares of the company, accounting for 1

### [Shen Lian Biomedical expects a pre-loss, anticipating a net loss attributable to the parent company of 20 million yuan for the fiscal year 2025](https://longbridge.com/en/news/273487552.md)
*2026-01-23T08:39:06.000Z*
> Shen Lian Biomedical released its annual performance forecast for 2025, expecting a net loss attributable to shareholder